1887

Abstract

The cold-adapted (ca) and temperature-sensitive (ts) influenza master donor virus (MDV) B/USSR/60/69 was derived from its wild-type parental virus after successive passages in eggs at 32 °C and 25 °C. This strain is currently in use for preparing reassortant influenza B vaccine viruses which are used in the Russian trivalent live attenuated influenza vaccine. Vaccine viruses are obtained by classical reassortment of MDV and a currently circulating wild-type virus. The phenotypic properties cold adaptation and temperature sensitivity are inherited from the six genes encoding the internal proteins of the MDV. However, the role of the individual gene segments in temperature sensitivity and thus attenuation is not known. In this study, 35 reassortant viruses of B/USSR/60/69 MDV with current wild-type non-ts influenza B viruses were generated in eggs or MDCK cells and studied in order to identify the genes responsible for their ts phenotype. For each virus the exact genome composition was determined as well as its ts phenotype. The results demonstrated that the polymerase PB2 and PA gene segments of B/USSR/60/69 MDV independently controlled expression of the ts phenotype of B/USSR/60/69 MDV-based reassortant viruses. The other genes coding for internal proteins played no role in this respect. This suggests that mutations in the polymerase genes PB2 and PA play an essential role in attenuation of B/USSR/60/69 MDV-based reassortant influenza B vaccine viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.017996-0
2010-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/4/931.html?itemId=/content/journal/jgv/10.1099/vir.0.017996-0&mimeType=html&fmt=ahah

References

  1. Alexandrova, G. I.(1971). Basic trends in vaccination of children against influenza by use of live vaccines. In Proceedings of the Symposium on Live Influenza Vaccine, pp. 121–127. Zagreb: Yugoslav Academy of Sciences and Arts.
  2. Alexandrova, G. I.(1996). Live influenza vaccine in Russia. In Proceedings of ‘Options for the Control of Influenza III', Cairns, Australia, 4–9 May 1996. ICS 1123, pp. 123–128. Edited by L. E. Brown, A. W. Hampson & R. G. Webster. Amsterdam: Elsevier.
  3. Alexandrova, G. I. & Klimov, A. I.(1994).Live Influenza Vaccine in Russia. St Petersburg: Nauka (in Russian).
  4. Donabedian, A. M., DeBorde, D. C. & Maassab, H. F.(1987). Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence. Microb Pathog 3, 97–108.[CrossRef] [Google Scholar]
  5. Donabedian, A. M., DeBorde, D. C., Cook, S., Smitka, C. W. & Maassab, H. F.(1988). A mutation in the PA protein gene of cold-adapted B/Ann Arbor/1/66 influenza virus associated with reversion of temperature sensitivity and attenuated virulence. Virology 163, 444–451.[CrossRef] [Google Scholar]
  6. Hoffmann, E., Mahmood, K., Chen, Z., Yang, C.-F., Spaete, J., Greenberg, H. B., Herlocher, M. L., Jin, H. & Kemble, G.(2005). Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol 79, 11014–11021.[CrossRef] [Google Scholar]
  7. Jin, H., Lu, B., Zhou, H., Ma, C., Zhao, J., Yang, C., Kemble, G. & Greenberg, H.(2003). Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306, 18–24.[CrossRef] [Google Scholar]
  8. Kiseleva, I., Klimov, A., Su, Q., Szymkowiak, C., Toner, T. J., Kwan, W.-S., Rudenko, L., Shaw, A. R. & Youil, R.(2003). Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature sensitive phenotype of reassortant influenza A viruses. In Proceedings of ‘Options for the Control of Influenza V', Okinawa, Japan, 7–11 October 2003. ICS 1263, pp. 547–550. Edited by Y. Kawaoka. Amsterdam: Elsevier.
  9. Kiseleva, I., Sua, Q., Toner, T. J., Szymkowiak, C., Kwan, W.-S., Rudenko, L., Shaw, A. R. & Youil, R.(2004). Cell-based assay for the determination of temperature sensitive and cold-adapted phenotypes of influenza viruses. J Virol Methods 116, 71–78.[CrossRef] [Google Scholar]
  10. Klimov, A. I. & Cox, N. J.(1995). PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods 52, 41–49.[CrossRef] [Google Scholar]
  11. Klimov, A. I., Cox, N. J., Yotov, W. V., Rocha, E., Alexandrova, G. I. & Kendal, A. P.(1992). Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology 186, 795–797.[CrossRef] [Google Scholar]
  12. Klimov, A. I., Romanova, J. R., Egorov, A. Y., Lukashok, I. V., Kiseleva, I. V., Alexandrova, G. I. & Cox, N. J.(1995). Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants. Virus Genes 10, 95–98.[CrossRef] [Google Scholar]
  13. Klimov, A. I., Kiseleva, I. V., Alexandrova, G. I. & Cox, N. J.(2001). Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus. In Proceedings of ‘Options for the Control of Influenza IV', Hersonissos, Crete, Greece, 23–28 September 2000. ICS 1219, pp. 955–959. Edited by A. D. M. E. Osterhaus, N. Cox & A. W. Hampson. Amsterdam: Elsevier.
  14. Maassab, H. F.(1967). Adaptation and growth characteristics of influenza virus at 25 °C. Nature 213, 612–614.[CrossRef] [Google Scholar]
  15. McCauley, J. W. & Penn, C. R.(1990). The critical cut-off temperature of avian influenza viruses. Virus Res 17, 191–198.[CrossRef] [Google Scholar]
  16. Reed, L. J. & Muench, H.(1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493–497. [Google Scholar]
  17. Romanova, J., Katinger, D., Ferko, B., Vcelar, B., Sereinig, S., Kuznetsov, O., Stukova, M., Erofeeva, M., Kiselev, O. & other authors(2004). Live cold-adapted influenza A vaccine produced in Vero cell line. Virus Res 103, 187–193.[CrossRef] [Google Scholar]
  18. Rudenko, L. G., Slepushkin, A. N., Monto, A. S., Kendal, A. P., Grigorieva, E. P., Burtseva, E. P., Rekstin, A. R., Beljaev, A. L., Bragina, V. E. & other authors(1993). Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 168, 881–887.[CrossRef] [Google Scholar]
  19. Rudenko, L. G., Kiseleva, I. V., Larionova, N. V., Grigorieva, E. P., Naikhin, A. N. & Alexandrova, G. I.(2003). Analysis of some factors influencing immunogenicity of live cold-adapted reassortant influenza vaccines. In Proceedings of ‘Options for the Control of Influenza V’, Okinawa, Japan, 7–11 October 2003. ICS 1263, pp. 542–546. Edited by Y. Kawaoka. Amsterdam: Elsevier.
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.017996-0
Loading
/content/journal/jgv/10.1099/vir.0.017996-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error